연구동향 분석

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy

김민균 한원식 문형곤 안수경 김지선 이준우 김주연 김태령 이경훈 김태용 한세원 임석아 김태유 박인애 노동영 2015년

논문상세정보
인용/피인용
' Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • breast neoplasms
  • neoadjuvant therapy
  • nomograms
  • segmental mastectomy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,437 0

0.0%

' Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy' 의 참고문헌

  • Reliability of prognostic factors in breast carcinoma determined by core needle biopsy
    Usami S Jpn J Clin Oncol 37 : 250 ~ 255 [2007]
  • Reliability of prognostic factors in breast carcinoma determined by core needle biopsy
    Usami S Jpn J Clin Oncol 37 250-255 [2007]
  • Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
    Jerevall PL Br J Cancer 104 : 1762 ~ 1769 [2011]
  • Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
    Jerevall PL Br J Cancer 104 1762-1769 [2011]
  • Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    Rastogi P J Clin Oncol 26 : 778 ~ 785 [2008]
  • Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    Rastogi P J Clin Oncol 26 778-785 [2008]
  • Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
    Rouzier R J Clin Oncol 23 : 8331 ~ 8339 [2005]
  • Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
    Rouzier R J Clin Oncol 23 8331-8339 [2005]
  • Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
    Keam B J Cancer Res Clin Oncol 137 : 1301 ~ 1308 [2011]
  • Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
    Keam B J Cancer Res Clin Oncol 137 1301-1308 [2011]
  • Neoadjuvant versus adjuvant systemic treatment in breast cancer : a meta-analysis
    Mauri D J Natl Cancer Inst 97 : 188 ~ 194 [2005]
  • Neoadjuvant versus adjuvant systemic treatment in breast cancer : a meta-analysis
    Mauri D J Natl Cancer Inst 97 188-194 [2005]
  • Neoadjuvant chemotherapy for locally advanced breast cancer
    Specht J Semin Radiat Oncol 19 : 222 ~ 228 [2009]
  • Neoadjuvant chemotherapy for locally advanced breast cancer
    Specht J Semin Radiat Oncol 19 222-228 [2009]
  • Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention
    Keun-YoungYoo Journal of Korean Medical Science 17 (1) : 1 ~ 6 [2002]
  • Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention
    Keun-YoungYoo Journal of Korean Medical Science 17 1 1-6 [2002]
  • Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer
    Rouzier R Cancer 107 : 1459 ~ 1466 [2006]
  • Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer
    Rouzier R Cancer 107 1459-1466 [2006]
  • Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients
    Shin HC Ann Surg Oncol 20 : 2582 ~ 2589 [2013]
  • Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients
    Shin HC Ann Surg Oncol 20 2582-2589 [2013]
  • Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors
    Rouzier R Cancer 101 : 918 ~ 925 [2004]
  • Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors
    Rouzier R Cancer 101 918-925 [2004]
  • Breast volumes in cancer of the breast
    Katariya RN Br J Cancer 29 : 270 ~ 273 [1974]
  • Breast volumes in cancer of the breast
    Katariya RN Br J Cancer 29 270-273 [1974]
  • Breast cancer in Asia
    Yip CH Methods Mol Biol 471 : 51 ~ 64 [2009]
  • Breast cancer in Asia
    Yip CH Methods Mol Biol 471 51-64 [2009]
  • Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy
    Mathieu MC Ann Oncol 23 : 2046 ~ 2052 [2012]
  • Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy
    Mathieu MC Ann Oncol 23 2046-2052 [2012]
  • Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained
    O'Leary R J Clin Pathol 57 : 193 ~ 195 [2004]
  • Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained
    O'Leary R J Clin Pathol 57 193-195 [2004]
  • A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer
    Colleoni M Eur J Cancer 46 : 2216 ~ 2224 [2010]
  • A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer
    Colleoni M Eur J Cancer 46 2216-2224 [2010]
  • A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
    Hatzis C JAMA 305 : 1873 ~ 1881 [2011]
  • A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
    Hatzis C JAMA 305 1873-1881 [2011]
  • A five-gene molecular grade index and HOXB13 : IL17BR are complementary prognostic factors in early stage breast cancer
    Ma XJ Clin Cancer Res 14 : 2601 ~ 2608 [2008]
  • A five-gene molecular grade index and HOXB13 : IL17BR are complementary prognostic factors in early stage breast cancer
    Ma XJ Clin Cancer Res 14 2601-2608 [2008]